|
|
|
|
|
Inactive Indication- |
Drug Highest PhaseApproved |
First Approval Ctry. / Loc.KR |
First Approval Date25 Oct 2024 |
100 Clinical Results associated with CorePharm Co., Ltd.
0 Patents (Medical) associated with CorePharm Co., Ltd.
100 Deals associated with CorePharm Co., Ltd.
100 Translational Medicine associated with CorePharm Co., Ltd.